Post-myocardial infarction ventricular septal defects: incidence and treatment trends during and after the COVID-19 pandemic
- PMID: 39747983
- PMCID: PMC11695627
- DOI: 10.1038/s41598-024-84983-z
Post-myocardial infarction ventricular septal defects: incidence and treatment trends during and after the COVID-19 pandemic
Abstract
Ventricular septal defect (VSD) is a serious complication of myocardial infarction (MI), with its global incidence significantly reduced in recent years due to advances in coronary reperfusion techniques. However, during the COVID-19 pandemic, there was an unexpected rise in the incidence of post-MI VSD, likely driven by delays in seeking treatment. This study retrospectively analyzed 10 cases of post-MI VSD treated at our hospitals from March 2018 to August 2023, comparing incidence rates across pre-pandemic, pandemic, and post-pandemic periods. The findings revealed a notable increase in VSD cases during the pandemic, with six cases occurring in two years, compared to only two cases in each of the pre-pandemic and post-pandemic periods. Despite these fluctuations, surgical intervention remained a crucial and effective treatment, with 60% of patients surviving the 30-day follow-up. The study underscores the impact of delayed treatment on VSD incidence during the pandemic and highlights the critical need for timely medical intervention to manage severe MI complications effectively.
Keywords: COVID-19 pandemic; Delayed treatment; Myocardial infarction; Post-MI complications; Surgical correction; Ventricular Setpal defect.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Institutional review board statement: The study conforms to the ethical principles of the Good Clinical Practice, the Helsinki Declaration, and is in compliance with the current Italian regulations. This study was approved by the Institutional Review Board of Anthea Hospital-Bari, code 011-2024, date 31 January 2024. Informed consent: Informed consent was obtained from all subjects involved in the study and written informed consent has been obtained from the patient(s) to publish this paper. Patient confidentiality was maintained by anonymizing data and using secure databases for data storage and analysis.
Figures



Similar articles
-
Increased incidence of postmyocardial infarction ventricular septal defects during Covid-19 pandemic: A case series.J Card Surg. 2022 Jun;37(6):1759-1763. doi: 10.1111/jocs.16430. Epub 2022 Mar 21. J Card Surg. 2022. PMID: 35315186 Free PMC article.
-
Surgical repair of post myocardial infarction ventricular septal defect: a retrospective analysis of a single institution experience.J Cardiothorac Surg. 2023 Nov 10;18(1):313. doi: 10.1186/s13019-023-02418-8. J Cardiothorac Surg. 2023. PMID: 37950265 Free PMC article.
-
Post-myocardial Infarction Ventricular Septal Defect in the Setting of No-Reflow and COVID.Cureus. 2023 Jul 7;15(7):e41525. doi: 10.7759/cureus.41525. eCollection 2023 Jul. Cureus. 2023. PMID: 37551229 Free PMC article.
-
Simultaneous Left Ventricular Aneurysm and Ventricular Septal Rupture Complicating Delayed STEMI Presentation: A Case-Based Review of Post-MI Mechanical Complications Amid the COVID-19 Pandemic.J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211031135. doi: 10.1177/23247096211031135. J Investig Med High Impact Case Rep. 2021. PMID: 34259086 Free PMC article. Review.
-
Techniques, Timing, and Prognosis of Transcatheter Post Myocardial Infarction Ventricular Septal Defect Repair.Curr Cardiol Rep. 2019 May 20;21(7):59. doi: 10.1007/s11886-019-1142-8. Curr Cardiol Rep. 2019. PMID: 31111245 Review.
Cited by
-
Presentation of a residual post-myocardial infarction ventricular septal defect; a literature review based on a case report.J Cardiothorac Surg. 2025 May 9;20(1):230. doi: 10.1186/s13019-025-03440-8. J Cardiothorac Surg. 2025. PMID: 40341071 Free PMC article. Review.
References
-
- Lu, L., Liu, M., Sun, R. R., Zheng, Y. & Zhang, P. Myocardial infarction: symptoms and treatments. Cell. Biochem. Biophys.72, 865–867 (2015). - PubMed
-
- Murphy, A. & Goldberg, S. Mechanical complications of myocardial infarction. Am. J. Med.135, 1401–1409 (2022). - PubMed
-
- Neumann, F. J. et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur. Heart J.40, 87–165 (2019). - PubMed
-
- Crenshaw, B. S. et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. Circulation101, 27–32 (2000). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical